Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

February 10, 2012: Cellular, Tissue and Gene Therapies Meeting: Agenda

Meeting, #55, Teleconference
National Institutes of Health, Building 29B, Conference Room A-B
Bethesda, Maryland
February 10, 2012

Open Session  
2:00 p.m. (EST)Call to Order and Opening Remarks
Roll Call
Conflict of Interest Statement
Steven Dubinett, M.D., Chair
Gail Dapolito
Designated Federal Officer
2:10Overview - Research Program
Center for Biologics Evaluation
and Research (CBER), FDA
Carolyn Wilson, Ph.D.
Associate Director for Research, CBER
2:35Overview – Research Programs
Office of Cellular, Tissue and
Gene Therapies, Division of Cellular
and Gene Therapies, CBER, FDA
Raj Puri, M.D., Ph.D.
Director, Division of Cellular and Gene
Therapies, FDA
2:50Research Highlights – Gene and
Tissue Therapy Branch, Division of
Cellular, Tissue and Gene Therapies

Steven Bauer, Ph.D.
Chief, Cellular and Tissue Therapy Branch, FDA

3:20Open Public Hearing 
4:20Closed Session 
5:00 p.m.Adjourn 

Page Last Updated: 10/13/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English